WILLIS TOWERS WATSON PLC

Explore how Baupost Group’s Q2 rebalancing—selling Willis Towers Watson and Vaxcyte while buying Amazon, Alphabet, CME, and more—shifts risk, growth, and market influence.

Willis Towers Watson COO sells shares yet hikes holdings to 10,000+—an insider move that may signal confidence and impact investor sentiment.

Arthur J. Gallagher’s Q2 2026 report shows $2.37 B revenue, 10%+ brokerage growth, and a 26.3% EBITDA margin, underlining strong organic expansion and clean‑energy focus.

Willis Towers Watson Q2 2026 earnings reveal a 9% revenue rise but falling net income, raising questions on interest income, AI plans and share repurchases.

Q2 2026: SBI Life’s double‑digit GWP growth, 12.4% profit margin and 4.2× solvency confirm its market‑leadership and strong digital expansion—investors should watch its resilient balance sheet and persistency gains.

Willis Towers Watson’s July 17 Form 4 filings reveal modest executive share moves, strong SEC compliance, and a new life‑sciences leader, underscoring steady governance and growth potential.

Willis Towers Watson’s July 2026 insider‑transaction filing shows routine equity‑compensation moves, underscoring the company’s solid ESG, cyber‑risk, and data‑analytics focus for future growth.

Willis Towers Watson expands climate‑risk solutions with fast‑acting parametric insurance, cross‑sector risk‑transfer tools, and public‑private resilience partnerships.

Willis Towers Watson PLC faces rising cyber‑security and climate claims, but its AI‑driven underwriting and data analytics may unlock undervalued upside for investors.

Explore how Willis Towers Watson PLC leverages AI, climate risk analytics, and dynamic pricing to drive modest 9% share‑price growth in a transforming insurance market.